# Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-teriflunomide-compared-to-interferon-beta-1b-for-relapsing/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yan Xu,Mao Ningying,Viktor Chirikov,Fen Du,Yu‐Chen Yeh,Li Liu,Ruiqi Liu,Xin Gao |
| Citations | 23 |
| DOI | 10.1007/s40261-019-00750-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40261-019-00750-3.pdf |
| OpenAlex ID | https://openalex.org/W2912714397 |
| PMID | 30684251 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Fen Du](https://scholariq.org/researchers/fen-du/)

## Paper journal

- [Clinical Drug Investigation](https://scholariq.org/journals/clinical-drug-investigation/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Viral Infections and Immunology Research](https://scholariq.org/topics/viral-infections-and-immunology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.